Hank Kucheman, Boston Scientific Interim CEO, and Michael Mahoney, Boston Scientific Icoming CEO, shed insight on a pro-longed CEO transition and pricing pressures in the device industry.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT